EXTERNAL DEFIBRILLATION/ CARDIOVERSION PROTOCOL IN PATIENTS WITH AN IMPLANTED CARDIOVERTER DEFIBRILLATOR OR PACEMAKER: SYSTEMATIC REVIEW AND META-ANALYSIS

EXTERNAL DEFIBRILLATION/ CARDIOVERSION PROTOCOL IN PATIENTS WITH AN IMPLANTED CARDIOVERTER DEFIBRILLATOR OR PACEMAKER: SYSTEMATIC REVIEW AND META-ANALYSIS

Maurizio Santomauro^1*, Mario Petretta², Carla Riganti³, Andrea Santomauro¹, Francesco Maffettone¹, Gaetano Castellano⁴, Pasquale Abete¹ and Francesco Cacciatore¹

¹Department of Cardiovascular Emergency, Internal Medicine and Geriatric, University of Naples “Federico II” – Italy ²Istituto di Ricovero e Cura a Carattere Scientifico, I.R.C.C.S.  S.D.N., Napoli ³General Direction, AOU Federico II, University of Naples “Federico II” – Italy ⁴Department of Anesthesia and Intensive Care, Gemelli Molise Hospital, Campobasso

Introduction: The use of cardiac implantable electronic devices (CIED) is increasing, and implanted patients require more often interventional procedures such as external defibrillation (ED) and electrical cardioversion (ECV). The creation of periprocedural care algorithms for patients with CIED is complex: the different programming capabilities of currently manufactured devices, confusion regarding the differences between pacemakers (PM) and implanted cardiac defibrillator (ICD), the use of old devices in some patients and lastly the continuous evolution in CIED technology with the introduction of leadless PM and subcutaneous implanted cardioverter defibrillators (S-ICD). Procedural advisories have been developed by professional societies, but the recommendations of these societies differ regarding to ED and ECV use.

Methods: We performed a systematic database search of studies published between January 2000 and October 2021 assessing ED and ECV by the selection process (PRISMA) and identified 5 prospective eligible articles. Two meta-analyses assessed the proportion of patients with complications and the proportion of patients with no clinicallly relevant parameter modifications, respectively.

Results: The final population for the meta-analysis included 2077 patients. The meta-analysis showed a weighted random pooled effect size of 0.55% (95% CI = 0.04% − 1.06 %) for complications, and of  22.4% (95% CI = 2.03% – 42.7%) for no clinically relevant modification parameters.

Conclusions: Our review indicates that few dysfunctions are detectable in patients with chest implanted CIED treated with ECV or ED. When an impanted patient undergoes ECV or ED procedures, caution is needed including CIED interrogation before and after the procedure.

Keywords: external defibrillation, electrical cardioversion, pacemaker, implanted cardioverter defibrillator, cardiac implanted electrical devices, emergency electrophysiology procedures

Free Full-text PDF

How to cite this article:
Maurizio Santomauro, Mario Petretta, Carla Riganti, Andrea Santomauro, Francesco Maffettone, Gaetano Castellano, Pasquale Abete and Francesco Cacciatore. External Defibrillation/Cardioversion Protocol in Patients with an Implanted Cardioverter Defibrillator or Pacemaker: Systematic Review and Meta-analysis. American Journal of Cardiology Research and Reviews, 2022, 5:20. DOI:10.28933/ajcrar-2021-11-2505

References:

1.Swiryn S, Orlov MV, Benditt DG, et al RATE Registry Investigators. Clinical implications of brief device-detected atrial tachyarrhythmias in a cardiac rhythm management device population: results from the registry of atrial tachycardia and atrial fibrillation episodes. Circula-tion. 2016;134:1130–1140 doi: 10.1161/CIRCULATIONAHA.115.020252.
2.Rienstra M, Hobbelt AH, Alings M, et al.; RACE 3 Investigators. Targeted therapy of underlying conditions improves sinus rhythm maintenance in patients with persistent atrial fibrillation: re-sults of the RACE 3 trial. Eur Heart J. 2018;39:2987–2996 doi: 10.1093/eurheartj/ehx739.
3.Kirchhof P, Benussi S, Kotecha D, et al.; ESC Scientific Document Group. 2016 ESC Guide-lines for the management of atrial fibrillation developed in collaboration with EACTS Eur Heart J. 2016; 37:2893–2962 doi: 10.1093/eurheartj/ehw210.
4.January CT, Wann LS, Calkins H, et al. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration with the Society of Thoracic Sur-geons. Circulation 2019; 140:e125–e151 doi: 10.1016/j.jacc.2019.01.011.
5.Steinberg BA, Holmes DN, Ezekowitz MD, et al. Rate versus rhythm control for management of atrial fibrillation in clinical practice: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) reg-istry. Am Heart J. 2013;165:622–629 doi: 10.1016/j.ahj.2012.12.019
6.Ruwald AC, Vinther M, Gislason GH, Johansen JB, Nielsen JC, Petersen HH, Riahi S, Jons C. The impact of co-morbidity burden on ap-propriate implantable cardioverter defibrillator therapy and all-cause mortality: insight from Danish nationwide clinical registers. Eur J Heart Fail 2017;19:377–386 doi: 10.1002/ejhf.685
7.Ruwald AC, Pietrasik G, Goldenberg I, et al. The effect of intermittent atrial tachyarrhythmia on heart failure or death in cardiac resynchroniza-tion therapy with defibrillator versus implantable cardioverter-defibrillator patients: a MADIT-CRT substudy (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchroniza-tion Therapy). J Am Coll Cardiol. 2014;63:1190–1197 doi: 10.1016/j.jacc.2013.10.074.
8.Aylward P, Blood R, Tonkin A Complications of defibrillation with permanent pacemaker in situ Pacing Clin Electrophysiol 1979;2:462-464.doi: 10.1111/j.1540-8159.1979.tb05222.x.
9.Waller C, Callies F, Langenfeld H Adverse ef-fects of direct current cardioversion on cardiac pacemakers and electrodes Is external cardio-version contraindicated in patients with perma-nent pacing systems? Europace 2004;6:165–168 doi: 10.1016/j.eupc.2003.11.003
10.Martino A, Scapigliati A, Casella M et al. Cardiac pacemaker battery discharge after external electrical cardioversion for broad QRS complex tachycardia. Indian Pacing Electrophysiol J 2008;8:222e6
11.Botkin SB, Dhanekula LS, Olshansky B Outpa-tient cardioversion of atrial arrhythmias: effica-cy, safety, and costs. Am Heart J 2003;145:233–238 doi: 10.1067/mhj.2003.112
12.Manegold JC, Israel CW, Ehrlich JR, et al Ex-ternal cardioversion of atrial fibrillation in pa-tients with implanted pacemaker or cardiovert-er-defibrillator systems: a randomized compar-ison of monophasic and biphasic shock energy application. Eur Heart J 2007;28:1731–1738 doi: 10.1093/eurheartj/ehm211.
13.Lüker J, von Bodman G, Sultan A, et al.. Safety and efficacy of external electrical cardioversion in patients with left ventricular leads. Clin Res Cardiol. 2015;104:439–445 doi: 10. 1007/s00392-014-0800-5
14.Lüker J, Sultan A, Plenge T, et al. Electrical cardioversion of patients with implanted pace-maker or cardioverter-defibrillator: results of a survey of German centers and systematic review of the literature. Clin Res Cardi-ol. 2018;107:249–258 doi: 10.1007/s00392-017-1178-y.
15.Lüker J, Kuhr K, Sultan A et al. Internal Versus External Electrical Cardioversion of Atrial Ar-rhythmia in Patients With Implantable Cardio-verter-Defibrillator Circulation 2019;140:1061-1069 doi.org/10.1161/CIRCULATIONAHA.119.041320
16.Untereker DF, Viste M Power Sources and Ca-pacitors for Pacemakers and Implantable Car-dioverter-Defibrillators in Clinical Cardiac pac-ing, Defibrillator and Resynchronization Therapy Edited by: Ellenbogen KA, Wilkoff BL, Kay GN, Lau GP, Auricchio A, Elservier Inc. Fifty Edition, 2017.doi:10.1016/B978-0-323-37804-8.00008-0.
17.Page RL, Kerber RE, Russell JK, et al. BiCard Investigators. Biphasic versus monophasic shock waveform for conversion of atrial fibrilla-tion: the results of an international randomized, double-blind multicenter trial. J Am Coll Cardiol 2002;39:1956e63 doi: 10.1016/s0735-1097(02)01898-3.
18.Alegret JM, Viñolas X, Sagristá J, et al RE-VERSE Study Investigators. Predictors of success and effect of biphasic energy on elec-trical cardioversion in patients with persistent atrial fibrillation. Europace 2007; 9:942–946.doi.org/10.1093/europace/eum107
19.Santomauro M, Borrelli A, Ottaviano L, et al. Transthoracic cardioversion in patients with atrial fibrillation: comparison of three different waveforms. Ital Heart J 2004 Suppl;5(1):36-43
20.Ricard P, Lévy S, Boccara G, et al. External cardioversion of atrial fibrillation: comparison of biphasic vs monophasic waveform shocks. Europace. 2001;3(2):96-99 doi.org/10.1053/eupc.2001.0156
21.Gammage MD. External cardioversion in pa-tients with implanted cardiac devices: is there a problem? Eur Heart J. 2007 Jul;28(14):1668-1669 doi: 10.1093/eurheartj/ehm214
22.Das G, Eaton J. Pacemaker malfunction fol-lowing transthoracic countershock. Pacing Clin Electrophysiol. 1981;4: 487-90 doi: 10.1111/j.15408159.1981.tb06215.x
23.Kaszala K Evaluation, troubleshooting, and management of pacing system malfunctions Cardiac Pacing and ICDs, 7th Edition 2020 doi: 10.1002/9781119578376
24.Levine PA, Barold SS, Fletcher RD, et al. Ad-verse acute and chronic effects of electrical defibrillation and cardioversion on implanted unipolar cardiac pacing systems. J Am Coll Cardiol. 1983;1:1413-22
25.Gould L, Patel S, Gomes GI, et al. Pacemaker failure following external defibrillation. Pacing Clin Electrophysiol. 1981;4:575-7 doi.org/10.1111/j.1540-8159.1981.tb06230.x
26.Waller C, Callies F, Langenfeld H Adverse ef-fects of direct current cardioversion on cardiac pacemakers and electrodes: Is external cardi-oversion contraindicated in patients with per-manent pacing systems? EP Europace, 2004;6:165–168 doi: 10.1016/j.eupc.2003.11.003
27.Haines DE, Wang Y, Curtis J Implantable car-dioverter-defibrillator registry risk score models for acute procedural complications or death after implantable cardioverter-defibrillator im-plantation. Circulation 2011;123:2069–2076 doi: 10.1161/CIRCULATIONAHA.110.959676.
28.Altamura G, Bianconi L, Lo Bianco F, et al Transthoracic DC shock may represent a serious hazard in pacemaker dependent patients. Pac-ing Clin Electrophysiol. 1995;18:194–198 doi:10.1111/j.1540-8159.1995.tb02503.x.
29.Beinart R, Nazarian S. Effects of external elec-trical and magnetic fields on pacemakers and defibrillators: from engineering principles to clinical practice. Circulation 2013;128:2799-809 doi:10.1161/CIRCULATIONAHA.113.005697
30.ECC GUIDELINES- Part 4: The Automated Ex-ternal Defibrillator- Implanted pacemaker and cardioverter-defibrillator systems (devices) Circulation 2000;102 (suppl 1):60-76 doi.org/10.1161/circ.102.suppl_1.I-60
31.2005 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care, Part 5: Electrical Therapies Automated External Defibrillators, Defibrillation, Cardioversion, and Pacing. Circulation 2005;112:35-46 doi.org/10.1161/CIRCULATIONAHA.105.166554
32.Practice Advisory for the Perioperative Man-agement of Patients with Cardiac Implantable Electronic Devices: Pacemakers and Implanta-ble Cardioverter-Defibrillators: An Updated Report by the American Society of Anesthesi-ologists Task Force on Perioperative Manage-ment of Patients with Cardiac Implantable Elec-tronic Devices Anesthesiology 2011; 114: 247–261 doi: 10.1097/ALN.0b013e3181fbe7f6
33.Practice Advisory for the Perioperative Management of Patients with Cardiac Implantable Electronic Devices: Pacemakers and Implantable Cardioverter–Defibrillators 2020: An Updated Report by the American Society of Anesthesiologists Task Force on Perioperative Management of Patients with Cardiac Implantable Electronic Devices. Anesthesiology 2020; 132: 225–252.
doi.org/10.1097/ALN.0000000000002821
34.Israel CW, Nowak B, Willems S, et al Empfeh-lungen zur externen Kardioversion bei Patienten mit Herzschrittmacher oder implantiertem Kar-dioverter/Defibrillator. Der Kardiologe 2011;5:257–263 doi: 10.1007/s12181-011-0372-9
35.Kirchhof P, Eckhardt L, Loh P, et al. Anterior–posterior versus anterior–lateral electrode posi-tions for external cardioversion of atrial fibrilla-tion: a randomised trial. Lancet 2002;360:1275–1279 doi: 10.1016/s0140-6736(02)11315-8.
36.Link MS, Atkins DL, Passman RS, et al. Part 6: Electrical Therapies Automated External Defib-rillators, Defibrillation, Cardioversion, and Pac-ing 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emer-gency Cardiovascular Care Circula-tion 2010;122,suppl 3,S706-S719 doi: 10.1161/CIRCULATIONAHA.110.970954.
37.McMullan J , Valento M, Attari M, et al. Care of the pacemaker/implantable cardioverter defib-rillator patient in the ED Am J Emerg Med 2007;25:812-22 doi: 10.1016/j.ajem.2007.02.008.
38.Schulz N, Püschel K, Turk EE Fatal com-plications of pacemaker and implantable car-dioverter-defibrillator implantation: medical malpractice? Interact Cardiovasc Thorac Surg. 2009; 8: 444-448 doi.org/10.1510/icvts.2008.189043
39.Allison MG, Mallemat HA Emergency Care of Patients with Pacemakers and Defibrillators. Emerg Med Clin North Am. 2015;33:653-667 doi: 10.1016/j.emc.2015.05.001.
40.Nishida T, Nakajima T, Goryo Y, et al Pacemaker System Malfunction Resulting from External Electrical Cardioversion: A Case Report J Ar-rhythmia 2009;25:209–213 doi:10.4020/jhrs.25.209
41.Montgomery JA, Orton JM, Ellis CR, Feasibility of Defibrillation and Pacing Without Trans-venous Leads in a Combined MICRA and S-ICD System Following Lead Extraction. J Cardio-vasc Electrophysiol; 2017;28:233-234 doi: 10.1111/jce.13111
42.Venier S, Jacon P, Defaye P. Direct electrical shock on a leadless pacemaker. J Intervent Card Electrophysiol 2017;49:39 doi: 10.1007/s10840-017-0230-1.
43.Ahmed FZ, Cunnington C, Motwani M, et al. Totally leadless dual-device implantation for combined spontaneous ventricular tachycardia defibrillation and pacemaker function: a first report. Can J Cardiol 2017;33:1066.e5e7.doi: 10.1016/j.cjca.2017.05.017.
44.Filipovic K, Bellmann B, Lüker J, et al External electrical cardioversion of persistent atrial fibrillation in a patient with a Micra™ Transcath-eter Pacing System Indian Pacing and Electro-physiology 2018;18:44-46 doi: 10.1016/j.ipej.2017.12.002
45.Pluymaekers NAHA, Dudink EAMP, Boersma L, et al. External electrical cardioversion in pa-tients with cardiac implantable electronic de-vices: Is it safe and is immediate device inter-rogation necessary? Pacing Clin Electro-physiol. 2018; 41:1336–1340 doi:10.1111/pace.13467.
46.Alaeddini J, Feng Z, Feghali G, et al. Repeated Dual External Direct Cardioversions Using Two Simultaneous 360‐J Shocks for Refractory Atrial Fibrillation Are Safe and Effective Pacing and Clinical Electrophysiology 2005; 28:3-7 doi: 10.1111/j.1540-8159.2005.09155.x
47.Drennan IR, Dorian P, McLeod S, et al. DOuble SEquential External Defibrillation for Refractory Ventricular Fibrillation (DOSE VF): study pro-tocol for a randomized controlled trial. Trials 2020;21:977 doi: 10.1186/s13063-020-04904-z.
48.Deakin CD, Morley P, Soar J, et al. Double (dual) sequential defibrillation for refractory ventricular fibrillation cardiac arrest: A system-atic review. Resuscitation 2020;155:24-31 doi: 10.1016/j. resuscitation.2020.06.008.
49.Lakkireddy DR, Chung MK, Gopinathannair R, et al. Guidance for Cardiac Electrophysiology During the Coronavirus (COVID-19) Pandemic From the Heart Rhythm Society COVID-19 Task Force; Electrophysiology Section of the Amer-ican College of Cardiology; and the Electrocar-diography and Arrhythmias Committee of the Council on Clinical Cardiology, American Heart Association. Heart Rhythm 2020;17:e233-e241 doi: 10.1016/j.hrthm. 2020. 03.028.